Abstract
Previously, most fractures have been treated through bone reduction and immobilization. With an increase in the patients’ need for an early return to their normal function, development in surgical techniques and materials have accelerated. However, delayed union or non-union of the fracture site sometimes inhibits immediate return to normal life. To enhance fracture healing, diverse materials and methods have been developed. This is a review on the current modalities of fracture healing enhancement, which aims to provide a comprehensive knowledge regarding fracture healing for researchers and health practitioners.
Similar content being viewed by others
References
Bhatt RA, Rozental TD. Bone graft substitutes. Hand Clin. 2012;28:457–68.
Pape HC, Evans A, Kobbe P. Autologous bone graft: properties and techniques. J Orthop Trauma. 2010;24:S36–40.
Fernandez-Bances I, Perez-Basterrechea M, Perez-Lopez S, Nuñez Batalla D, Fernandez Rodriguez MA, Alvarez-Viejo M, et al. Repair of long-bone pseudoarthrosis with autologous bone marrow mononuclear cell combined with allogenic bone graft. Cytotherapy. 2013;15:571–7.
Baldwin P, Li DJ, Auston DA, Mir HS, Yoon RS, Koval KJ. Autograft, allograft, and bone graft substitutes: clinical evidence and indications for use in the setting of orthopaedic trauma surgery. J Orthop Trauma. 2019;33:203–13.
Masquelet AC. Muscle reconstruction in reconstructive surgery: soft tissue repair and long bone reconstruction. Langenbecks Arch Surg. 2003;388:344–6.
Wang J, Yin Q, Gu S, Wu Y, Rui Y. Induced membrane technique in the treatment of infectious bone defect: a clinical analysis. Orthop Traumatol Surg Res. 2019;105:535–9.
Brinker MR, O’Connor DP. Exchange nailing of ununited fractures. J Bone Joint Surg Am. 2007;89:177–88.
Calori GM, Colombo M, Mazza EL, Mazzola S, Malagoli E, Mineo GV. Incidence of donor site morbidity following harvesting from iliac crest or RIA graft. Injury. 2014;45:S116–20.
Chiarello E, Cadossi M, Tedesco G, Capra P, Calamelli C, Shehu A, et al. Autograft, allograft and bone substitutes in reconstructive orthopedic surgery. Aging Clin Exp Res. 2013;25:S101–3.
Sohn HS, Oh JK. Review of bone graft and bone substitutes with an emphasis on fracture surgeries. Biomater Res. 2019;23:9.
Centers for Disease Control (CDC). Transmission of HIV through bone transplantation: case report and public health recommendations. MMWR Morb Mortal Wkly Rep. 1988;37:597–9.
Zamborsky R, Svec A, Bohac M, Kilian M, Kokavec M. Infection in bone allograft transplants. Exp Clin Transplant. 2016;14:484–90.
Aslantürk O, Akman YE, Öztürk H, Eltayeb MEM, Küçükkaya M, Hamzaoğlu A. “Sandwich technique” with dual strut allograft in surgical treatment of femoral nonunion. Injury. 2020;51:1057–61.
Ullmark G, Obrant KJ. Histology of impacted bone-graft incorporation. J Arthroplast. 2002;17:150–7.
Garrison KR, Shemilt I, Donell S, Ryder JJ, Mugford M, Harvey I, et al. Bone morphogenetic protein (BMP) for fracture healing in adults. Cochrane Database Syst Rev. 2010;2010:CD006950.
Devescovi V, Leonardi E, Ciapetti G, Cenni E. Growth factors in bone repair. Chir Organi Mov. 2008;92:161–8.
Eckardt H, Ding M, Lind M, Hansen ES, Christensen KS, Hvid I. Recombinant human vascular endothelial growth factor enhances bone healing in an experimental nonunion model. J Bone Joint Surg Br. 2005;87:1434–8.
Kawaguchi H, Oka H, Jingushi S, Izumi T, Fukunaga M, Sato K, et al. A local application of recombinant human fibroblast growth factor 2 for tibial shaft fractures: a randomized, placebo-controlled trial. J Bone Miner Res. 2010;25:2735–43.
Li M, Ke HZ, Qi H, Healy DR, Li Y, Crawford DT, et al. A novel, non-prostanoid ep2 receptor-selective prostaglandin e2 agonist stimulates local bone formation and enhances fracture healing. J Bone Miner Res. 2003;18:2033–42.
Feigenson M, Jonason JH, Shen J, Loiselle AE, Awad HA, O’Keefe RJ. Inhibition of the prostaglandin ep-1 receptor in periosteum progenitor cells enhances osteoblast differentiation and fracture repair. Ann Biomed Eng. 2020;48:927–39.
Zimmermann G, Moghaddam A. Allograft bone matrix versus synthetic bone graft substitutes. Injury. 2011;42:S16–21.
Oliveira HL, Da Rosa WLO, Cuevas-Suárez CE, Carreño NLV, da Silva AF, Guim TN, et al. Histological evaluation of bone repair with hydroxyapatite: a systematic review. Calcif Tissue Int. 2017;101:341–54.
Zhang H, Yang L, Yang XG, Wang F, Feng JT, Hua KC, et al. Demineralized bone matrix carriers and their clinical applications: an overview. Orthop Surg. 2019;11:725–37.
Ho-Shui-Ling A, Bolander J, Rustom LE, Johnson AW, Luyten FP, Picart C. Bone regeneration strategies: engineered scaffolds, bioactive molecules and stem cells current stage and future perspectives. Biomaterials. 2018;180:143–62.
Šponer P, Kučera T, Brtková J, Urban K, Kočí Z, Měřička P, et al. Comparative study on the application of mesenchymal stromal cells combined with tricalcium phosphate scaffold into femoral bone defects. Cell Transplant. 2018;27:1459–68.
Bohner M, Santoni BLG, Döbelin N. β-tricalcium phosphate for bone substitution: synthesis and properties. Acta Biomater. 2020;113:23–41.
Zwingenberger S, Nich C, Valladares RD, Yao Z, Stiehler M, Goodman SB. Recommendations and considerations for the use of biologics in orthopedic surgery. BioDrugs. 2012;26:245–56.
DiGiovanni CW, Lin SS, Baumhauer JF, Daniels T, Younger A, Glazebrook M, et al. Recombinant human platelet-derived growth factor-BB and beta-tricalcium phosphate (rhPDGF-BB/β-TCP): an alternative to autogenous bone graft. J Bone Joint Surg Am. 2013;95:1184–92.
Kelly CM, Wilkins RM, Gitelis S, Hartjen C, Watson JT, Kim PT. The use of a surgical grade calcium sulfate as a bone graft substitute: results of a multicenter trial. Clin Orthop Relat Res. 2001;382:42–50.
Fernandez de Grado G, Keller L, Idoux-Gillet Y, Wagner Q, Musset AM, Jessel-Benkirane N, et al. Bone substitutes: a review of their characteristics, clinical use, and perspectives for large bone defects management. J Tissue Eng. 2018;9:2041731418776819.
Hofmann A, Gorbulev S, Guehring T, Schulz AP, Schupfner R, Raschke M, et al. Autologous iliac bone graft compared with biphasic hydroxyapatite and calcium sulfate cement for the treatment of bone defects in tibial plateau fractures: a prospective, randomized, open-label, multicenter study. J Bone Joint Surg Am. 2020;102:179–93.
Turner TM, Urban RM, Hall DJ, Infanger S, Gitelis S, Petersen DW, et al. Osseous healing using injectable calcium sulfate-based putty for the delivery of demineralized bone matrix and cancellous bone chips. Orthopedics. 2003;26:S571–5.
Hartshorne E. On the causes and treatment of pseudarthrosis and especially that form of it sometimes called supernumerary joint. Am J Med Sci. 1841;1:121–56.
Einhorn, TA. Enhancement of fracture-healing. J Bone Joint Surg Am. 1995;77:940–56.
Moretti B, Notarnicola A, Moretti L, Patella S, Tatò I, Patella V. Bone healing induced by ESWT. Clin Cases Miner Bone Metab. 2009;6:155–8.
Leal C, D’Agostino C, Gomez Garcia S, Fernandez A. Current concepts of shockwave therapy in stress fractures. Int J Surg. 2015;24:195–200.
Bara T, Synder M. Nine-years experience with the use of shock waves for treatment of bone union disturbances. Ortop Traumatol Rehabil. 2007;9:254–8.
Chen YJ, Wurtz T, Wang CJ, Kuo YR, Yang KD, Huang HC, et al. Recruitment of mesenchymal stem cells and expression of TGF-beta 1 and VEGF in the early stage of shock wave-promoted bone regeneration of segmental defect in rats. J Orthop Res. 2004;22:526–34.
Rutten S, van den Bekerom MPJ, Sierevelt IN, Nolte PA. Enhancement of bone-healing by low-intensity pulsed ultrasound: a systematic review. JBJS Rev. 2016;4:e6.
Kim KW, Ha KY, Moon MS, Kim YS, Kwon SY, Woo YK. Volumetric change of the graft bone after intertransverse fusion. Spine. 1999;24:428–33.
Kim SJ, Jang JD, Lee SK. Treatment of long tubular bone defect of rabbit using autologous cultured osteoblasts mixed with fibrin. Cytotechnology. 2007;54:115–20.
Kim SJ, Shin YW, Yang KH, Kim SB, Yoo MJ, Han SK, et al. A multi-center, randomized, clinical study to compare the effect and safety of autologous cultured osteoblast (OssronTM) injection to treat fractures. BMC Musculoskelet Disord. 2009;10:20.
Hong SH, Bahk WJ, Yang SJ, Kim KW, Kim SJ, Chang CH, et al. Osteogenecity and biomechanical properties of autologous osteoblast cells mixed with fibrin. Tissue Eng Regen Med. 2009;6:52–6.
Park HY, Shetty AA, Kim JM, Kim YJ, Jang JD, Choi NY, et al. Enhancement of healing of long tubular bone defects in rabbits using a mixture of atelocollagen gel and bone marrow aspirate concentrate. Cells Tissues Organs. 2017;203:339–52.
Kim SJ, Shettey AA. Stem cell research in orthopaedic and trauma surgery. In: Shetty AA, Kim SJ, Nakamura N, Brittberg M, editors. Techniques in cartilage repair surgery. Springer: Berlin, Heidelberg; 2014. p. 215–55.
Braly HL, O’Connor DP, Brinker MR. Percutaneous autologous bone marrow injection in the treatment of distal meta-diaphyseal tibial nonunions and delayed unions. J Orthop Trauma. 2013;27:527–33.
Gianakos A, Ni A, Zambrana L, Kennedy JG, Lane JM. Bone marrow aspirate concentrate in animal long bone healing: an analysis of basic science evidence. J Orthop Trauma. 2016;30:1–9.
Van Vugt TAG, Geurts JAP, Blokhuis TJ. Treatment of infected tibial non-unions using a BMAC and S53P4 BAG combination for reconstruction of segmental bone defects: A clinical case series. Injury. 2021;52:S67–71.
Lin K, VandenBerg J, Putnam SM, Parks CD, Spraggs-Hughes A, McAndrew CM, et al. Bone marrow aspirate concentrate with cancellous allograft versus iliac crest bone graft in the treatment of long bone nonunions. OTA Int. 2019;2:e012.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
We declare that we have no conflicts of interest and ethical issue in the authorship or publication of this contribution.
Ethical statement
There are no animal experiments carried out for this article.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Chun, Y.S., Lee, D.H., Won, T.G. et al. Current Modalities for Fracture Healing Enhancement. Tissue Eng Regen Med 19, 11–17 (2022). https://doi.org/10.1007/s13770-021-00399-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13770-021-00399-0